1. Home
  2. Popular Articles
  3. Induced Pluripotent Stem Cells: recapitulating disease to facilitate drug discovery

Induced Pluripotent Stem Cells: recapitulating disease to facilitate drug discovery

Axol Bioscience Ltd

Read about how iPSC-derived cells can enhance your drug development research by offering a physiologically relevant model that can represent a disease population enabling research in many different stages of the development pipeline.

This white paper includes examples where iPSC-derived cells have been used in target identification, target validation, lead optimisation, and safety testing in order to reduce failure rates of drug candidates.

Download our white paper and discover how hiPSCs are an invaluable tool in drug discovery.

Share this post:

Related Posts

Previous
Using human iPSC-derived cortical neurons for the early prediction of neurotoxicity
Next
ELRIG Research & Innovation 2018